Literature DB >> 16528576

[Assessing psychopathic personality disorders for legal procedures for using a version for adolescents of Hare's revised checklist].

K Sevecke1, M Krischer, P Walger, G Lehmkuhl, H Flechtner.   

Abstract

In accordance with Robert Hare's concept, the term psychopathy was operationalized in 1985 when the revised form of the psychopathy checklist (PCL-R) was published. Since then, the PCL-R has been used internationally. For several years in North America and now even in England and the Netherlands, personality traits of psychopathy have also been studied in children and juveniles. Based on the PCL-R, a checklist for adolescents (PCL-YV) was developed that takes the special conditions of adolescents into account. The goal of this paper was to test the applicability of the PCL-YV retrospectively in a sample of forensic psychiatric evaluations of delinquent juveniles that were assigned to the Clinic for Child and Adolescent Psychiatry at the University of Cologne, Germany. Based on results collected with the PCL-YV, data on groups of low- and medium-scoring juveniles were classified which partially differed significantly in relation to sociodemographic and anamnestic data. Furthermore, factor analyses showed a three-factor model solution. Associations with legal issues such as the question of criminal responsibility could not be found. In summary, the results indicate the applicability of the PCL-YV for adolescents but show the difficulties of retrospective design without conducting PCL interviews.

Entities:  

Mesh:

Year:  2007        PMID: 16528576     DOI: 10.1007/s00115-005-1999-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  9 in total

1.  Gender differences in regional cerebral activity during sadness.

Authors:  F Schneider; U Habel; C Kessler; J B Salloum; S Posse
Journal:  Hum Brain Mapp       Date:  2000-04       Impact factor: 5.038

2.  [Quantitative detection of dyssocial and psychopathic personalities in criminal expert assessment. Retrospective study of the value of the German version of the Hare Psychopathy Checklist].

Authors:  J Hartmann; M Hollweg; N Nedopil
Journal:  Nervenarzt       Date:  2001-05       Impact factor: 1.214

Review 3.  [The psychopathy-concept and its psychometric evaluation in childhood, adolescence and adulthood].

Authors:  K Sevecke; M K Krischer; M Döpfner; G Lehmkuhl
Journal:  Fortschr Neurol Psychiatr       Date:  2005-07       Impact factor: 0.752

4.  Psychopathy and substance use in adolescent male offenders.

Authors:  D L Mailloux; A E Forth; D G Kroner
Journal:  Psychol Rep       Date:  1997-10

5.  A brain imaging (single photon emission computerized tomography) study of semantic and affective processing in psychopaths.

Authors:  J Intrator; R Hare; P Stritzke; K Brichtswein; D Dorfman; T Harpur; D Bernstein; L Handelsman; C Schaefer; J Keilp; J Rosen; J Machac
Journal:  Biol Psychiatry       Date:  1997-07-15       Impact factor: 13.382

6.  Is Hare's Psychopathy Checklist reliable without the interview?

Authors:  S Wong
Journal:  Psychol Rep       Date:  1988-06

7.  Comparison of procedures for the assessment of psychopathy.

Authors:  R D Hare
Journal:  J Consult Clin Psychol       Date:  1985-02

8.  A selective impairment in the processing of sad and fearful expressions in children with psychopathic tendencies.

Authors:  R J Blair; E Colledge; L Murray; D G Mitchell
Journal:  J Abnorm Child Psychol       Date:  2001-12

9.  Brain circuits involved in emotional learning in antisocial behavior and social phobia in humans.

Authors:  Ralf Veit; Herta Flor; Michael Erb; Christiane Hermann; Martin Lotze; Wolfgang Grodd; Niels Birbaumer
Journal:  Neurosci Lett       Date:  2002-08-16       Impact factor: 3.046

  9 in total
  1 in total

1.  [Structured psychiatric assessment of risk for violent recidivism in juvenile offenders].

Authors:  M Rieger; C Stadtland; F J Freisleder; N Nedopil
Journal:  Nervenarzt       Date:  2009-03       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.